{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1116.512","meta":{"versionId":"5","lastUpdated":"2018-07-24T01:07:49.000-04:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.512","version":"20180724","name":"System Reasons for Not Performing Flow Cytometry","status":"active","date":"2018-07-24T01:00:01-04:00","publisher":"American Society of Clinical Oncology Steward","compose":{"include":[{"system":"http://www.ama-assn.org/go/cpt","version":"2021","concept":[{"code":"3170F","display":"Flow cytometry studies performed at time of diagnosis or prior to initiating treatment (HEM)"},{"code":"3P","display":"Performance Measure Exclusion Modifier due to System Reasons"}]}]},"expansion":{"identifier":"urn:uuid:407e4cc8-91e2-4c16-889a-f5ca7ccd45a2","timestamp":"2022-06-10T12:22:48-04:00","total":2,"offset":0,"parameter":[{"name":"count","valueInteger":1000},{"name":"offset","valueInteger":0}],"contains":[{"system":"http://www.ama-assn.org/go/cpt","version":"2021","code":"3170F","display":"Baseline flow cytometry studies performed at time of diagnosis or prior to initiating treatment (HEM)"},{"system":"http://www.ama-assn.org/go/cpt","version":"2021","code":"3P","display":"Performance Measure Exclusion Modifier due to System Reasons"}]}}